ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigate Risperidone for the Treatment of Schizophrenia in Adolescents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00088075
Recruitment Status : Completed
First Posted : July 21, 2004
Last Update Posted : June 8, 2011
Sponsor:
Information provided by:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.